Drugs Made In America Acquisition II Corp. (DMIIR) Stock Analysis

What Drugs Made In America Acquisition II Corp. does

Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.

Key metrics

ETFs linked to DMIIR

Broad-market and Financial Services sector ETFs an investor holding Drugs Made In America Acquisition II Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DMIIR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Drugs Made In America Acquisition II Corp.?

Drugs Made In America Acquisition II Corp. trades under the ticker DMIIR on NASDAQ.

Which exchange is DMIIR listed on?

DMIIR is listed on NASDAQ.

What sector does Drugs Made In America Acquisition II Corp. operate in?

Drugs Made In America Acquisition II Corp. is classified in the Financial Services sector (Financial - Conglomerates industry).

How can PortView help analyze DMIIR in a portfolio?

PortView shows DMIIR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.